Errors in Text, Figure, and End Matter

Abstract

In the Original Contribution entitled "Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore" 1 published online in JAMA on March 3, 2020, there were errors in the text, a figure, and the end matter. In the second paragraph of the "Case Management" section in the text, the dose for coformulated lopinavir-ritonavir reported as 200 mg/100 mg should have been reported as 400 mg/100 mg. At the top right of Figure

Topics & Concepts